Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen-Generating Agent and Skin Graft Survival in Rats

Hydrogen-generating Si-based agent protects against skin flap ischemia-reperfusion injury in rats

Research hubs: Skin & Dermatology System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Hydrogen-generating Si-based agent protects against skin flap ischemia-reperfusion injury in rats
Evidence type
Animal study (rat)
Authors
Naoya Otani, Koichi Tomita, Yuki Kobayashi, Kazuya Kuroda, Yoshihisa Koyama, Hikaru Kobayashi, Tateki Kubo
Journal
Scientific Reports
Year
2022
Study Type
Rat
Delivery
Gas (Sustained Release)
Dose
Si-based agent administered perioperatively
Outcome
Positive
Peer Reviewed
Yes
Cited by
14 (OpenAlex, as of November 2026)
Country
Japan

TL;DR

An orally administered silicon-based agent helps protect skin grafts from damage caused by temporary loss and restoration of blood flow.

Key Finding

An orally administered silicon-based hydrogen-generating agent significantly improved skin flap survival in rats undergoing ischemia-reperfusion injury by reducing oxidative stress, inflammation, and cell death.

Summary

Researchers tested whether a silicon-based substance that generates hydrogen gas in the stomach could protect skin tissue during a surgical procedure in rats. When skin flaps are surgically moved and blood flow is temporarily cut off then restored, the tissue can be damaged by oxidative stress (harmful chemical reactions) and inflammation. Rats given the silicon-based agent before and after surgery had better skin flap survival and showed lower levels of tissue damage, inflammation, and cell death compared to rats that didn't receive it.

Practical Takeaway

This is an early-stage animal study suggesting that a hydrogen-generating oral supplement may help protect tissue during reconstructive surgery. However, this research was conducted only in rats, and the study does not report sample size or duration details. Much more research, including human trials, would be needed before any clinical recommendations could be made.

Abstract (excerpt)

Hydrogen is effective against ischemia-reperfusion (I/R) injury in skin flaps. However, the difficulty of continuously administering a sufficient amount of hydrogen using conventional methods has been an issue in the clinical application of hydrogen-based therapy. An Si-based agent administered…

Read the full abstract on PubMed